Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

Novofactory Receives Flawless FDA Assessment

CG Bio, a regenerative medicine company, said its Novofactory facility in Hwaseong, Gyeonggi Province, concluded an on-site FDA inspection of human tissue operations with zero findings.

  • FDA gave CG Bio's Novofactory facility a flawless assessment in September.
  • Inspection covered quality management, donor verification, and traceability.
  • Novofactory set for completion in March will boost business and partnerships.

More from Tuesday 17 November →